In Vitro Diagnostics (IVD) Quality Control Market GLOBAL INDUSTRY ANALYSIS, TRENDS, MARKET SIZE AND FORECASTS UP TO 2023
In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
Š Infinium Global Research
Page 2
In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
We have produced a new premium report In Vitro Diagnostics (IVD) Quality Control Market. The report covers the analysis of global as well as regional markets of In Vitro Diagnostics (IVD) Quality Control. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of In Vitro Diagnostics (IVD) Quality Control Market by segment products and services (data management solutions, quality control products), application (immunochemistry, microbiology), manufacturer type (OEMS, third-party control manufacturers), end user (clinical laboratories, hospitals, research and academic institutes) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the In Vitro Diagnostics (IVD) Quality Control Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global In Vitro Diagnostics (IVD) Quality Control Market are Roche Diagnostics, Thermo Fisher Scientific Inc., Helena Laboratories, Randox Laboratories Ltd, Seracare Life Sciences, Inc., Sero as, Technopath Clinical Diagnostics., Ortho Clinical Diagnostics, Inc., Abbott Laboratories Inc., and Bio-Rad Laboratories, Inc. According to report the Global In Vitro Diagnostics (IVD) Quality Control Market is expected to grow at a CAGR between 3.0% and 3.5 % over the forecast period of 2017 - 2023. For More Details Get Free Few Sample Pages of this Premium Report: https://www.infiniumglobalresearch.com/reports/sample-request/714 The Emerging Markets are expected to Provide Opportunities for Major Players in the In Vitro Diagnostics (IVD) Quality Control Market to Expand The report identified that Global In Vitro Diagnostics (IVD) Quality Control is driven by factors such as Rising Demand for External Quality Assessment (EQA) Support, Number of Accredited Clinical Laboratories are increasing, Acceptance of Third-Party Quality Controls is Increased, and Government Regulation. While the restraining factors include High Cost of In Vitro Diagnostics (IVD) Quality Control in Hospitals and Laboratories. Further, the report identifies the opportunities in the world market as Rising Demand for Multi-Analyte Controls. Segments Covered The report on Global In Vitro Diagnostics (IVD) Quality Control Market covers the segments based on Products and Services, Application, Manufacturer Type andEnd User. The Products and Services of In Vitro Diagnostics (IVD) Quality Control include Data Management Solutions, Quality Control Products and Quality Assurance Services. The Š Infinium Global Research
Page 3
In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
Application segment includes Immunochemistry, Microbiology, Clinical Chemistry, Molecular Diagnostics, Clinical Chemistry, Hematology and Other Applications. On the basis of Manufacturer Type the Global In Vitro Diagnostics (IVD) Quality Control Market is segmented as OEMS, Third-Party Control Manufacturers. On the basis of End User Clinical Laboratories, Hospitals, Research and Academic Institutes and Other End Users. Asia Pacific Market is expected to grow at the Highest CAGR over the Forecast Period 2017-2023 The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography are provided over the period of 2017 – 2023.Globally, North America market dominated the world In Vitro Diagnostics (IVD) Quality Control Market followed by Europe and Asia-Pacific. Furthermore, Asia Pacific market is expected to grow at the highest CAGR over the forecast period 2017-2023. Due to fast growth in the number of accredited laboratories and increasing use of quality control products in this region. Major Key Players Mentioned in this Research Report The report provides profiles of the companies in the Global In Vitro Diagnostics (IVD) Quality Control Market such as, Roche Diagnostics, Thermo Fisher Scientific Inc., Helena Laboratories, Randox Laboratories Ltd, Seracare Life Sciences, Inc., Sero as, Technopath Clinical Diagnostics., Ortho Clinical Diagnostics, Inc., Abbott Laboratories Inc., and Bio-Rad Laboratories, Inc. Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-in-vitrodiagnostics-quality-control-market
Š Infinium Global Research
Page 4